Indeed, most ISGs are upregulated in CD4 and CD8 T cells from viremic untreated patients [5] [6] [7] and tend to diminish on antiretroviral therapy (ART). Whereas monocytes are important in HIV pathogenesis, 8 few studies have focused on ISGs regulation in monocytes from HIV-infected patients. 9 Little is known regarding the expression of ISGs in the rare patients who spontaneously control HIV replication [HIV controller patients (HICs)]. In peripheral blood mononuclear cells (PBMCs) from HICs, ifit1 and mxA seem overexpressed as compared with healthy donors (HDs) and ART-treated patients. 10 We have recently showed that plasma IP10 levels are higher in HICs than HDs and associated with low CD4 T-cell counts. 11 Other studies reported that some ISGs known to restrict HIV, such as samhd1, schlaffen 11, apobec3c, and apobec3d, might be overexpressed in CD4 T cells or PBMCs from HICs. [12] [13] [14] Here, we studied the expression of 4 ISGs in 3 sorted cell subtypes (CD4 and CD8 T lymphocytes, and monocytes). We compared their expressions between HICs, HIV-1-infected ART-treated patients (ARTs), viremic treatment-naive patients (VIRs), and HDs. The expression of these ISGs according to the levels of T-cell and monocyte activation was analyzed. A strong ifitm1 expression in CD4 T cells in HIV controllers was correlated with immune activation.
PATIENTS AND METHODS
HICs (n = 11) were enrolled in the ANRS CO21 CODEX cohort 11 with the following definition: known HIV diagnosis for at least 5 years before enrolment, with HIV viral load (VL) ,400 copies per milliliter in the last 5 consecutive measurements. ART-treated patients (n = 8) and VIRs (n = 8) were defined as previously reported. 11 HIVnegative HDs (n = 8) were recruited as controls. All patients gave their informed consent for this study, in accordance with the Declaration of Helsinki.
Freshly collected PBMCs were stained with the following conjugated monoclonal antibodies: PE-CD14, PerCP Cy5.5-CD8, APC-CD3, and APC-H7-CD4, before the Fluorescence-activated cell sorting-based sorting procedure on BD ARIA (BD Biosciences, Franklin Lakes, NJ). CD4 + T cells, CD8 + T cells, and monocytes (CD3 − CD14 + ) were sorted and immediately lysed in RNeasy Lysis Buffer (QIAGEN SAS, Hilden, Germany) and cryopreserved at −80°C. RNA isolation and reverse transcription were performed according to the manufacturers' protocols (RNeasy Mini Kit; Qiagen; and enhanced avian RT-PCR Kit, SIGMA-ALDRICH, St. Louis, MO, respectively).
Quantitative reverse transcriptase-polymerase chain reaction analysis was performed using a SyBR Green RT PCR method (LightCycler System; Roche Life Science, Indianapolis, IN). All results were normalized for gapdh expression.
Levels of soluble CD14 (sCD14) were determined by enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, MN), and the surface expression of HLA-DR and CD38 on T cells was analyzed by flow cytometry, as described previously. 11 For statistical analyses, continuous variables were compared using the nonparametric Kruskal-Wallis test followed by Dunn test for multiple analysis. Categorical variables were compared using x 2 test, and Spearman coefficient was used for correlation analyses. The threshold for statistical significance was set to P , 0.05. Data were stored and analyzed using PRISM software (version 5; GraphPad Software, La Jolla, CA).
RESULTS
The characteristics of the study population are summarized in the Supplemental Digital Content, Table 1 (http://links.lww.com/QAI/A899). There was no difference in age and gender between each group of patients.
ifitm1 Expression Is Elevated in CD4 T Cells From HICs
The analysis of ISGs expression in the 4 groups and the 3 cell subtypes is depicted in Figure 1 . In VIRs, the expression of ifitm1 in monocytes, pkr in all cell types, mxA in CD4 and CD8 T cells, and ifit1 in CD4 were higher than in ARTs, suggesting a strong role of the virus in the induction of ISGs. Similar results were seen when comparing ISGs expression between VIRs and HICs, except for mxA in all cell types and ifit1 in CD8 T cells and monocytes, for which the expressions were similar in the 2 groups.
Importantly, we found that the expression of ifitm1 expression in CD4 T cells from HICs (P = 0.01) and ARTs (P = 0.001) was similar to VIRs and higher than HDs. In contrast, the expression of ifitm1 in CD8 T cells and monocytes and those of the other genes in the 3 cell subtypes were similar in HICs and in HDs.
Expression of Most ISGs Is Correlated Positively With HIV Viral Load
In view of these observations, we hypothesized that the expression of most ISGs was associated with the HIV VL. Indeed, pooling the data of all HIV-infected patients, the HIV VL was significantly correlated with the expression of pkr in CD4 T cells, CD8 T cells, and monocytes, as well as mxA in CD4 and CD8 T cells, and with ifit1 in CD4 T cells. Of note, similar results were obtained when classifying the HIV VL into categorical variables (ie, detectable or undetectable). Also, when considering all HIVinfected patients, the CD4 T-cell count was negatively correlated with the expression of pkr in CD4 T cells and monocytes (with a strong trend for CD8 T cells), and ifit1 only in CD4 T cells, but not with mxA expression.
Interestingly, the expression of ifitm1 was associated with the HIV VL in monocytes only but was negatively correlated with CD4 count in every cell subtypes. These results suggested that ifitm1 expression could depend on other conditions than the amount of virus itself, especially in T cells. 
DISCUSSION
We selected 4 ISGs with distinct production mechanisms and reported their expression in 3 cell subsets in 4 groups of individuals. pkr and ifit1 expressions depend on the engagement of type I IFN but can be also directly stimulated by HIV RNA or particles. 15, 16 mxA seems to be directly correlated with type I IFN, with a strong link with HIV VL. 17 Conversely, ifitm1 expression depends on type I IFN, but also type II IFN, with strong links to the proinflammatory milieu. 16 Consequently, viremic patients had higher levels of pkr in each cell subtypes, mxA in CD4 and CD8 T cells, and ifit1 in CD4 T cells than the other groups. The correlation between these ISGs and the HIV VL support the role of viral particles in their production. [5] [6] [7] 18 The most striking point was the finding that in HICs' CD4 T cells, ifitm1 was overexpressed compared with HDs, whereas no differences were found between HICs and HD for the other ISGs. This observation extends previous results from gene expression profiling of CD4 T cells from HICs but had never been quantified by reverse transcriptase-polymerase chain reaction in sorted cells. 13, 14 ifitm1 has been recently described as part of a HIV-1 restriction factor family. 19, 20 Moreover, it has been suggested that ifitm1 might be induced by interleukin 6 or other acute-phase cytokines. 16 This is consistent with our observations that ifitm1 was globally linked with immune activation but barely with the VL, the correlation being still present only when HICs are studied.
It seems important to separately analyze the expression of ISGs in purified CD4 T cells and monocytes because the role of monocytes in the pathophysiology of HIV and inflammation is increasing. The analysis of the ex vivo purified monocytic compartment has seldom been reported in the field of ISG expression. Indeed, we observed that the expression profile of most ISGs was different between CD4 T cells and monocytes, suggesting that the individualization of these cell types might better decipher the mechanisms of ISGs regulation in the setting of HIV infection.
Our results show that the expression profile of ISGs in HIV-infected patients varies according to the cell type, the disease status, and the gene considered, with multiple regulation mechanisms beyond type I/II IFNs. Importantly, the gene expression profiles in monocytes should be distinguished from that in CD4 T cells. In HICs, ifitm1 seems to have a unique expression profile and is associated with immune CD4 T-cell activation. Its putative role in HIV pathogenesis and antiviral control deserves further investigations. 
